Clinical orthopaedics and related research
-
Clin. Orthop. Relat. Res. · Dec 2016
Randomized Controlled TrialIs Botulinum Toxin Type A a Valuable Adjunct During Femoral Lengthening? A Randomized Trial.
Reduced joint ROM and distraction-induced pain are common complaints of patients who have undergone gradual femoral lengthening. Attempts to reduce the effects of lengthening on joint motion have included the use of botulinum toxin to reduce the muscle forces that restrict motion. The benefits of this approach during femoral lengthening, however, have not been conclusively established. ⋯ Level II, therapeutic study.